Clinical Trials
3 trialsNCT00006518 2026-06-05
Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer
National Institutes of Health Clinical Center (CC)
Recruiting
NCT05907759 2026-06-02
Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman Disease
National Institutes of Health Clinical Center (CC)
Phase 2 Recruiting
NCT04968288 2026-06-01
Natural History of KSHV-Associated Multicentric Castleman s Disease
National Institutes of Health Clinical Center (CC)
Recruiting